Bacteriophage-based treatment (Intralytix/Biophage Therapeutics)

N/A

Report date: 2025/09/29 17:48:53

Base Information

Drug NameBacteriophage-based treatment (Intralytix/Biophage Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Bacteriophages
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWounds and InjuriesStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntralytix Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntralytix IncBioPhage Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsWounds and InjuriesStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A